Roche Holdings' (NASDAQ:RHHBY) gross profit will grow in mid-single digits in 2018, primarily led by the company's pharmaceuticals business, which accounts for roughly 85% of its overall profits, according to our estimates. We have created an interactive dashboard on Roche's sensitivity to changes..
Roche Holdings' (NASDAQ:RHHBY) gross profit will grow in mid-single digits in 2018, primarily led by the company's pharmaceuticals business, which accounts for roughly 85% of its overall profits, according to our estimates. We have created an interactive dashboard on Roche's sensitivity to changes..
Share this Article
Recommended